These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11036436)

  • 1. [Drug interactions in practice].
    Hoppe-Tichy T; Simon K; Hentze BW
    Ther Umsch; 2000 Sep; 57(9):563-7. PubMed ID: 11036436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple "colour code system"].
    Vogel Kahmann I; Bürki R; Denzler U; Höfler A; Schmid B; Splisgardt H
    Anaesthesist; 2003 May; 52(5):409-12. PubMed ID: 12750824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infusion mixtures--study of clinical practice in Austria].
    Haslinger-Matzenauer M; Karger H; Kirchdorfer K; Petcold L; Rosmann van Goethem J; Kerbl H; Zadravec S
    Infusionstherapie; 1991 Jun; 18(3):114-20. PubMed ID: 1917052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug stability and compatibility in oncology care.
    Williams DA
    J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of infusion solutions to reduce the risk of incompatibility.
    Nemec K; Kopelent-Frank H; Greif R
    Am J Health Syst Pharm; 2008 Sep; 65(17):1648-54. PubMed ID: 18714112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of multilumen infusion devices on the occurrence of known physical drug incompatibility: a controlled in vitro study.
    Foinard A; Décaudin B; Barthélémy C; Debaene B; Odou P
    Anesth Analg; 2013 Jan; 116(1):101-6. PubMed ID: 23223095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of medications during multi-infusion therapy: A controlled in vitro study on a multilumen infusion device.
    Perez M; Décaudin B; Foinard A; Barthélémy C; Debaene B; Lebuffe G; Odou P
    Anaesth Crit Care Pain Med; 2015 Apr; 34(2):83-8. PubMed ID: 25858619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug incompatibilities in the adult intensive care unit of a university hospital.
    Marsilio NR; Silva Dd; Bueno D
    Rev Bras Ter Intensiva; 2016 Jun; 28(2):147-53. PubMed ID: 27410410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of intravenous drug incompatibilities in an intensive care unit.
    Bertsche T; Mayer Y; Stahl R; Hoppe-Tichy T; Encke J; Haefeli WE
    Am J Health Syst Pharm; 2008 Oct; 65(19):1834-40. PubMed ID: 18796425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
    Baririan N; Chanteux H; Viaene E; Servais H; Tulkens PM
    J Antimicrob Chemother; 2003 Mar; 51(3):651-8. PubMed ID: 12615867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing waste of intravenous solutions.
    Diehl LD; Goo ED; Sumiye L; Ferrell R
    Am J Hosp Pharm; 1992 Jan; 49(1):106-8. PubMed ID: 1570849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study on the potential utility of GFP as a biosensor for drug stability in parenteral solutions.
    dos Santos CA; Mazzola PG; Silva PH; Cholewa O; Penna TC
    Biotechnol Prog; 2007; 23(4):979-84. PubMed ID: 17567040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of use and preparation of infusion mixtures. 3. Current opinion of the utilization of infusion mixtures in therapy].
    Samková M; Malý J
    Cesk Farm; 1971 Sep; 20(7):269-75. PubMed ID: 4999860
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures.
    Puzovic M; Hardy G
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):311-7. PubMed ID: 17414500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer support of pharmaceutical services for ambulatory patients.
    Weissman AM; Solomon DK; Baumgartner RP; Brady JA; Peterson JH; Knight JL
    Am J Hosp Pharm; 1976 Nov; 33(11):1171-5. PubMed ID: 998635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice.
    Rommers MK; Zwaveling J; Guchelaar HJ; Teepe-Twiss IM
    Artif Intell Med; 2013 Sep; 59(1):15-21. PubMed ID: 23664455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hospital pharmacist: an important contributor to improved patient safety in the hospital.
    Berthouzoz S; Berger L; Bonnabry P; Pannatier A
    Chimia (Aarau); 2012; 66(5):300-3. PubMed ID: 22867540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.